A critical advance in cancer research is arising with the use of nanobodies to reactivate mutated p53. This essential cancer protector protein is frequently inactivated in several forms of malignancies, leading https://bookmarkpressure.com/story21857535/mini-antibodies-restore-the-p53-protein-new-potential-pathway-for-tumor-management